Pharsight

Avanir Pharms patents expiration

1. Nuedexta patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8227484 AVANIR PHARMS Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Jul, 2023

(2 months ago)

US7659282 AVANIR PHARMS Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
Aug, 2026

(2 years from now)

Drugs and Companies using DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE ingredient

Market Authorisation Date: 29 October, 2010

Treatment: Treatment of pseudobulbar affect

Dosage: CAPSULE;ORAL

How can I launch a generic of NUEDEXTA before it's drug patent expiration?
More Information on Dosage

NUEDEXTA family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic